The Best Could Be Yet to Come for Novo Nordisk and Ozempic [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
future, the diabetes treatment has become well known on social media for its ability to help people lose weight. And that success has played a big role in Novo Nordisk (NYSE: NVO) becoming one of the most valuable healthcare companies in the world. But as well as things are going for the company, this may still only be the beginning for Novo Nordisk, Ozempic, and Wegovy (its approved weight-loss treatment). Here's why. Novo Nordisk is testing higher doses of semaglutide Semaglutide is the active ingredient in Ozempic and Wegovy. And that's why the two products are highly similar; Wegovy is essentially just a higher-dose version, and it is approved for weight loss. Novo Nordisk, however, is currently involved in clinical trials for even higher doses of semaglutide. This is key because if the doses are higher, the potential weight loss that is achievable could be greater. Both Ozempic and Wegovy are weekly injections, but Ozempic is a 2 mg dose, whereas Wegovy's maximum dosage i
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma [Yahoo! Finance]Yahoo! Finance
- 2seventy bio completes $40m haemophilia A program deal with Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal [Yahoo! Finance]Yahoo! Finance
- Weight-loss patients warned of counterfeit Ozempic as dupes popular of drug proliferate [USA TODAY]USA TODAY
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 6/26/24 - Form 6-K
- 6/24/24 - Form 6-K
- 6/21/24 - Form 11-K
- NVO's page on the SEC website